Valuation: KDventures AB

Market Cap 164M 17.01M 14.86M 13.74M 12.69M 23.9M 1.63B 24.33M 64.28M 800M 63.88M 62.46M 2.75B P/E 2024
-31.7x
P/E 2025 -0.61x
Enterprise Value 141M 14.64M 12.79M 11.83M 10.93M 20.58M 1.41B 20.95M 55.34M 689M 54.99M 53.77M 2.37B EV / Sales 2024
118x
EV / Sales 2025 56.8x
Free-Float
65.1%
Yield 2024 *
-
Yield 2025 -
1 day-0.60%
1 week-0.20%
Current month+2.26%
1 month-11.41%
3 months-5.33%
6 months-21.48%
Current year-43.00%
1 week 0.24
Extreme 0.2415
0.27
1 month 0.24
Extreme 0.2415
0.29
Current year 0.2
Extreme 0.2
0.45
1 year 0.2
Extreme 0.2
1.24
3 years 0.2
Extreme 0.2
1.95
5 years 0.2
Extreme 0.2
11.24
10 years 0.2
Extreme 0.2
11.24
Manager TitleAgeSince
Chief Executive Officer 61 2017-05-31
Director of Finance/CFO 58 2022-09-30
Chief Investment Officer - -
Director TitleAgeSince
Director/Board Member 33 2017-11-27
Director/Board Member 57 2021-02-18
Chairman 50 2024-12-17
Date Insider Type Main position Quantity % Market Cap.
23-03-26Buy

General Counsel

50,000 0.0187%
22-09-29Buy

General Counsel

40,187 0.0150%
22-03-07Buy

Chairman

64,001 0.0367%
Change 5-day change 1-year change 3-year change Capi.($)
-0.60%-0.20%-74.90%-84.57% 17.02M
-3.42%-7.18%-32.62%-17.58% 160B
-5.11%-5.40%-11.62%-9.53% 107B
-1.26%-0.72%+1.76%+57.91% 59.56B
-0.65%+6.25%+40.05%+55.81% 52.51B
-2.07%-3.61%-14.93%-41.92% 42.39B
-4.73%-10.11% - - 34.31B
-2.92%+0.75%-13.14%-46.02% 29.46B
-0.57%+0.44%+59.32%-7.14% 25.41B
-3.83%-3.09%-7.56%-8.88% 21.15B
Average -2.52%-2.49%-5.96%-11.32% 53.22B
Weighted average by Cap. -3.07%-3.99%-7.92%-1.93%

Financials

2024 2025
Net sales 1.84M 191K 167K 154K 142K 268K 18.33M 273K 721K 8.97M 717K 701K 30.9M 1.67M 173K 152K 140K 129K 244K 16.66M 248K 656K 8.16M 652K 637K 28.09M
Net income -8.1M -841K -735K -679K -628K -1.18M -80.77M -1.2M -3.18M -39.55M -3.16M -3.09M -136M -194M -20.12M -17.58M -16.26M -15.02M -28.28M -1.93B -28.79M -76.06M -946M -75.58M -73.91M -3.26B
Net Debt -39.9M -4.14M -3.62M -3.35M -3.09M -5.82M -398M -5.93M -15.65M -195M -15.56M -15.21M -671M -22.8M -2.37M -2.07M -1.91M -1.77M -3.33M -227M -3.39M -8.94M -111M -8.89M -8.69M -383M
Logo KDventures AB
Karolinska Development AB is a Sweden-based investment company. The Company provides capital to biotechnology firms, as well as develops and commercializes biotechnological products. Its activities are involved in a range of areas: oncology, infections and wound healing, women’s health, cardiovascular and hematology, medical equipment, diagnostics, pharmaceutical formulation, as well as implants, among others. The Company’s pharmaceuticals portfolio comprises: AXL1717 for non-small-cell lung carcinoma (NSCLC), APR-246 for ovarian cancer, Sevuparin for malaria, SHACT for pain relief at hysteroscopy and intrauterine device (IUD) insertion, and PC-mAB for acute coronary syndrome (ACS), among others. Furthermore, the Company controls a number of subsidiaries, such as Avaris AB, HBV Thernostica AB, KD Incentive AB, KDev Oncology AB and Limone AB.
Employees
7
Date Price Change Volume
26-07-14 SEK 0.2485 -0.60% 824,471
26-07-13 SEK 0.2500 -3.29% 560,168
26-07-10 SEK 0.2585 0.00% 1,166,566
26-07-09 SEK 0.2585 +0.39% 1,335,726
26-07-08 SEK 0.2575 +3.41% 105,485

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KDV B Stock